Study of the Brain Natriuretic Peptide in blood plasma after pneumonectomy and its role as a predictor of postoperative complications

2018 ◽  
Vol 49 (2) ◽  
Author(s):  
Nikolaos Baltayiannis ◽  
Michail Tsimpinos ◽  
Evangelia Grisbolaki ◽  
Antonios Chatzimichalis ◽  
Periklis Tomos
1994 ◽  
Vol 86 (6) ◽  
pp. 723-730 ◽  
Author(s):  
B. M. Y. Cheung ◽  
J. E. C. Dickerson ◽  
M. J. Ashby ◽  
M. J. Brown ◽  
J. Brown

1. Brain natriuretic peptide, closely related to atrial natriuretic peptide in structure, may be an important circulating hormone. Its physiological role is unclear. First, we studied the effects of incremental infusions of brain natriuretic peptide in six healthy men on plasma brain natriuretic peptide levels and the pharmacokinetics of brain natriuretic peptide. Synthetic human brain natriuretic peptide-32 was infused intravenously, at an initial rate of 0.4 pmol min−1 kg−1, doubling every 15 min until the dose rate reached 6.4 pmol min−1 kg−1, at which rate the infusion was maintained for 30 min. 2. The brain natriuretic peptide infusion raised the brain natriuretic peptide-like immunoreactivity from 1.4 ± 0.5 pmol/l to 21.4 ± 7.6 pmol/l. Brain natriuretic peptide-like immunoreactivity after the end of infusion was consistent with a bi-exponential decay, with half-lives of 2.1 min and 37 min. 3. Next, we studied the effects of low-dose infusion of brain natriuretic peptide to mimic physiological increments in the circulating levels in comparison with atrial natriuretic peptide. Six dehydrated male subjects received intravenous infusions of atrial natriuretic peptide and brain natriuretic peptide, separately and in combination, in a randomized double-blind, placebo-controlled, four-part cross-over design. Atrial natriuretic peptide and brain natriuretic peptide were given at the rate of 0.75 and 0.4 pmol min−1 kg−1, respectively, for 3 h. The control infusion consisted of the vehicle. 4. Analysis of variance showed that atrial natriuretic peptide and atrial natriuretic peptide plus brain natriuretic peptide, but not brain natriuretic peptide alone, increased urinary flow and decreased urinary osmolality significantly. However, urinary sodium excretion was significantly increased by atrial natriuretic peptide, brain natriuretic peptide and atrial natriuretic peptide plus brain natriuretic peptide. 5. None of the four infusates significantly altered the blood pressure, heart rate or glomerular filtration rate. 6. This study showed, for the first time, that physiological increments in brain natriuretic peptide, like those in atrial natriuretic peptide, are natriuretic. Although atrial natriuretic peptide and brain natriuretic peptide do not appear to interact synergistically, they are likely to act in concert in the physiological regulation of sodium balance.


2015 ◽  
Vol 55 (5) ◽  
pp. 603 ◽  
Author(s):  
Clive J. C. Phillips ◽  
Mohamed O. Mohamed ◽  
Paul C. Chiy

Sheep may adapt rumen function in response to supplementary sodium, potentially affecting the metabolism and accumulation of this element and related elements in target tissues and organs. In this study, sheep were provided with a supplement of sodium added to silage for 3, 6 or 9 weeks. There was no evidence of adaptation of rumen function that would have benefited digestion or element absorption, on the contrary, after 6 and 9 weeks supplementation compared with 3 weeks, the buffering capacity of rumen solids was reduced and their density increased, with long particles that were associated with high dry matter contents. Potassium concentration in kidneys increased after 9 week of supplementation, in conjunction with reduced bone potassium concentration. In addition, the concentration of cadmium, an element known to compete with sodium, increased in rumen contents and its availability decreased. Copper was increased in the brain and eyes after 9 weeks of supplementation with NaCl, and after 6 weeks, copper in blood plasma decreased. It is concluded that there was evidence of a dynamic response to NaCl supplementation, which affected rumen solids and the accumulation of several important elements in key target organs.


2020 ◽  
Vol 21 (7) ◽  
pp. 2347
Author(s):  
Chengyang Xu ◽  
Ang Zheng ◽  
Tianyi He ◽  
Zhipeng Cao

Background: Cardiac complications after a stroke are the second leading cause of death worldwide, affecting the treatment and outcomes of stroke patients. Cardiac biomarkers such as cardiac troponin (cTn), brain natriuretic peptide (BNP), and N-terminal pro-brain natriuretic peptide (NT-proBNP) have been frequently reported in patients undergoing a stroke. The aim of the present study is to meta-analyze the relationship between changes in such cardiac biomarkers and stroke and to present a systematic review of the previous literature, so as to explore the brain–heart axis. Methods: We searched four online databases pertinent to the literature, including PubMed, Embase, the Cochrane Library, and the Web of Science. Then, we performed a meta-analysis to investigate changes in cTn, BNP, and NT-proBNP associated with different types of stroke. Results and Conclusions: A significant increase in cTnI concentration was found in patients exhibiting a brain hemorrhage. BNP increased in cases of brain infarction, while the NT-proBNP concentration was significantly elevated in patients suffering an acute ischemic stroke and brain hemorrhage, indicating cardiac damage and dysfunction after a stroke. Our analysis suggests that several potential mechanisms may be involved in the brain–heart axis. Finally, clinicians should pay careful attention to monitoring cardiac function in the treatment of cerebrovascular diseases in order to provide a timely and more accurate treatment.


Gene ◽  
2021 ◽  
Vol 768 ◽  
pp. 145305
Author(s):  
Xiaolong Tian ◽  
Jun Ma ◽  
Yijing Wu ◽  
Pan Zhang ◽  
Qinggang Li ◽  
...  

2018 ◽  
Vol 64 (2) ◽  
pp. 183-187
Author(s):  
A.F. Yakimovskii ◽  
I.I. Shantyr ◽  
M.A. Vlasenko ◽  
M.V. Yakovleva ◽  
S.Yu. Kryzanovskaia

Zinc content in blood plasma and brain tissue of rats was studied by analytic mass-spectrometry with inductively coupled plasma. In control (saline-treated animal) zinc content in plasma was 3.6±1.4 mg/ml, in the liver – 12.5±2.5 mg/mg, in the spleen – 10.9±4.1 mg/mg, in the brain – 8.7±3.0 mg/mg. After a single intraperitoneal injection of zinc donator acizolum (24 mg/kg) zinc content decreased in all examined tissues, especially in brain. After a course of sequential acizolum injections (seven administrations during two weeks) essential elevation of zinc content in blood plasma and tissues investigated was detected. The maximal increase zinc concentration in blood plasma and liver was detected in 15 h after the last acizolum injections. Selen, calcium, copper and iron contents demonstrated a more complex behaviour. The obtained data suggest that prolonged acizolum administration has a significant impact on the bioelements content, and this should be taken into consideration when this zinc donator is used as a drug.


2005 ◽  
Vol 99 (5) ◽  
pp. 1676-1680 ◽  
Author(s):  
Morten Schou ◽  
Mads K. Dalsgaard ◽  
Otto Clemmesen ◽  
Ellen A. Dawson ◽  
Chie C. Yoshiga ◽  
...  

Renal metabolism of the cardiac marker NH2-terminal-pro-brain natriuretic peptide (NT-proBNP) has been suggested. Therefore, we determined the renal extraction ratios of NT-proBNP and its bioactive coproduct brain natriuretic peptide (BNP) at rest and during exercise. In addition, the cerebral ratios were evaluated. Ten young healthy men were investigated at baseline, during moderate cycle exercise (heart rate: 140, Borg scale: 14–15), and in the recovery with BNP and NT-proBNP measured from the brachial artery and the jugular and renal veins, and the renal and cerebral extraction ratios (Ext-Ren and Ext-Cer, respectively) were calculated. Cardiac output, stroke volume, heart rate, mean arterial pressures, and estimated glomerular filtration were determined. BNP and NT-proBNP were extracted by the kidneys but not by the brain. We observed no effect of exercise. The mean values (± SE) of Ext-Ren of NT-proBNP were similar (0.19 ± 0.05, 0.21 ± 0.06, and 0.12 ± 0.03, respectively) during the three sessions ( P > 0.05). Also the Ext-Ren of BNP were similar (0.18 ± 0.07, 0.15 ± 0.11, and 0.14 ± 0.06, respectively; P > 0.05). There were no significant differences between Ext-Ren of BNP and NT-proBNP during the three sessions ( P > 0.05). The Ext-Cer of both peptides varied insignificantly between −0.21 ± 0.15 and 0.11 ± 0.08. The renal extraction ratio of both BNP and NT-proBNP is ∼0.15–0.20. There is no cerebral extraction, and short-term moderate exercise does not affect these values. Our findings suggest that the kidneys extract BNP and NT-proBNP to a similar extent in healthy young men.


Sign in / Sign up

Export Citation Format

Share Document